参考文献/References:
[1] YU L C.Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers:exploring a common ground hypothesis[J].J Biomed Sci,2018,25(1):79.
[2] NI J,WU G D,ALBENBERG L,et al.Gut microbiota and IBD:causation or correlation?[J].Nat Rev Gastroenterol Hepatol,2017,14(10):573-584.
[3] 劳万江,左占国.温肾运脾柔肝法防治慢性难愈性结肠炎[J].临床心身疾病杂志,2016,22(z1):309.
[4] MALATY H M,LO G H,HOU J K.Characterization and prevalence of spondyloarthritis and peripheral arthritis among patients with inflammatory bowel disease[J].Clin Exp Gastroenterol,2017,10:259-263.
[5] 张晓哲,张栋,马玉峰,等.通络止痛凝胶制剂对膝骨关节炎大鼠的影响[J].中华中医药杂志,2019,34(5):2184-2188.
[6] 潘建科,罗斌,郭达,等.龙鳖胶囊对膝骨关节炎大鼠IL-1β、IL-6、IL-10水平的影响[J].中华中医药杂志,2015,30(5):1675-1679.
[7] KRIEGOVA E,MANUKYAN G,MIKULKOVA Z,et al.Gender-related differences observed among immune cells in synovial fluid in knee osteoarthritis[J].Osteoarthritis Cartilage,2018,26(9):1247-1256.
[8] MARTINEZ-NAVA G A,FERNANDEZ-TORRES J,MARTINEZ-FLORES K,et al.The association of AKNA gene polymorphisms with knee osteoarthritis suggests the relevance of this immune response regulator in the disease genetic susceptibility[J].Mol Biol Rep,2018,45(2):151-161.
[9] PETERS V,VAN DE STEEG E,VAN BILSEN J,et al.Mechanisms and immunomodulatory properties of pre-and probiotics[J].Benef Microbes,2019,10(3):1-12.
[10] DEHNER C,FINE R,KRIEGEL M A.The microbiome in systemic autoimmune disease:mechanistic insights from recent studies[J].Curr Opin Rheumatol,2019,31(2):201-207.
[11] KYRIACHENKO Y,FALALYEYEVA T,KOROTKYI O,et al.Crosstalk between gut microbiota and antidiabetic drug action[J].World J Diabetes,2019,10(3):154-168.
[12] MOOSSAVI S,BISHEHSARI F.Microbes:possible link between modern lifestyle transition and the rise of metabolic syndrome[J].Obes Rev,2019,20(3):407-419.
[13] SZYCHLINSKA M A,DI ROSA M,CASTORINA A,et al.A correlation between intestinal microbiota dysbiosis and osteoarthritis[J].Heliyon,2019,5(1):e1134.
[14] HOFFMANN T W,PHAM H P,BRIDONNEAU C,et al.Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice[J].ISME J,2016,10(2):460-477.
[15] OULDALI N,HUGOT J P,VIALA J,et al.Early arthritis is associated with failure of immunosuppressive drugs and severe pediatric crohn's disease evolution[J].Inflamm Bowel Dis,2018,24(11):2423-2430.
[16] SCHETT G,NEURATH M F.Resolution of chronic inflammatory disease:universal and tissue-specific concepts[J].Nat Commun,2018,9(1):3261.
[17] MATSUMOTO S,MASHIMA H.Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn's disease[J].Biologics,2018,12:69-73.
[18] SPECA S,DUBUQUOY L.Chronic bowel inflammation and inflammatory joint disease:pathophysiology[J].Joint Bone Spine,2017,84(4):417-420.
[19] ZHEN Y,ZHANG H.NLRP3 inflammasome and inflammatory bowel disease[J].Front Immunol,2019,10:276.
[20] HUANG Z,KRAUS V B.Does lipopolysaccharide-mediated inflammation have a role in OA?[J].Nat Rev Rheumatol,2016,12(2):123-129.
[21] BARRETO G,SANDELIN J,SALEM A,et al.Toll-like receptors and their soluble forms differ in the knee and thumb basal osteoarthritic joints[J].Acta Orthop,2017,88(3):326-333.
[22] MILLER R E,BELMADANI A,ISHIHARA S,et al.Damage-associated molecular patterns generated in osteoarthritis directly excite murine nociceptive neurons through Toll-like receptor 4[J].Arthritis Rheumatol,2015,67(11):2933-2943.
[23] ULICI V,KELLEY K L,AZCARATE-PERIL M A,et al.Osteoarthritis induced by destabilization of the medial meniscus is reduced in germ-free mice[J].Osteoarthritis Cartilage,2018,26(8):1098-1109.
[24] SANTISTEBAN M M,KIM S,PEPINE C J,et al.Brain-gut-bone marrow axis:implications for hypertension and related therapeutics[J].Circ Res,2016,118(8):1327-1336.